• Like
  • Comment
  • Favorite

Exosens’ Strategic Expansion and Strong Financial Outlook Earns Buy Rating and Top 10 European SMID Selection

TIPRANKS03-19

Aleksander Peterc, an analyst from Bernstein, reiterated the Buy rating on Exosens (EXENS – Research Report). The associated price target is €45.50...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet

7x24